Skip to main content
Autobound logo

Biogen news and events in 2026

Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities, to advance first-in-class...

Public (BIIB)Biotechnology Research10,000+ employeesbiogen.comLinkedIn

Dated updates
73
Last event
Sep 29, 2026
Open rolesSnapshot Sep 29, 2026
43
Latest SEC filing
Jul 29, 2026

Overview

Biogen by topic

Latest events

Latest Biogen events

All Biogen news →
  1. Launch
    Phase 3 Pediatric EMPAVELI Data Published in Clinical Journal of the American Society of Nephrology Show Reduction in Proteinuria and Stabilized Kidney Function in Adolescents...Biogen announced the publication of results from a Phase 3 study of its drug EMPAVELI® (pegcetacoplan) in the Clinical Journal of the American Society of Nephrology.
    globenewswire.com
  2. Launch
    LEQEMBI® Pen (Subcutaneous Formulation of LEQEMBI®) Approved in Japan for the Treatment of Early Alzheimer’s DiseaseWith Eisai Co., Ltd.
    globenewswire.com
  3. Recognition
    Canada’s Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement of LEQEMBI® (lecanemab) for Early Alzheimer’s DiseaseBiogen's drug LEQEMBI® (lecanemab) received a final positive recommendation supporting public reimbursement for early Alzheimer’s disease from Canada’s Drug Agency (CDA-AMC).
    globenewswire.com
  4. Integration
    Veeva Vault CRM Selected by BiogenWith Veeva Systems
    prnewswire.com
  5. Acquisition
    Biogen Completes Acquisition of Ray TheraBiogen has completed its acquisition of Ray Thera, a private biotechnology company, in a deal valued at up to $1 billion.
    pharmabiz.net
  6. Acquisition
    Biogen Completes Acquisition of RayThera Inc.Biogen has completed its acquisition of RayThera Inc., a biotechnology company focused on immunology therapies.
    globenewswire.com
  7. Revenue
    Biogen Boosts Profit Forecast with Growth Across Alzheimer's, Rare Disease PortfolioBiogen reported revenues of $2.736 billion, beating the consensus of $2.458 billion.
    benzinga.com
  8. Earnings
    Biogen reports Q2 2026: $2.74B revenue, GAAP EPS $0.66, Non‑GAAP EPS $3.60Biogen reported second-quarter 2026 GAAP diluted EPS of $0.66 and non-GAAP diluted EPS of $3.60.
    tradingview.com
  9. Partnership
    Biogen Inc. Stock Reacts After Quarterly Figures and Alzheimer Partnership with LillyWith Eli Lilly
    ad-hoc-news.de
  10. In development
    Biogen Wins FDA Approval for Subcutaneous Starter Dose of LeqembiWith Ionis Pharmaceuticals
    ca.finance.yahoo.com

Showing 10 of 20 events. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track Biogen with the Signal API

One POST /v1/companies/enrich call with biogen.com returns every signal type for Biogen, each with its source. Or ask Claude through MCP.

Start Free1,000 free creditsUse it in Claude via MCP

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"biogen.com","limit":20}'

Same industry

Companies related to Biogen

Biogen questions

What is the latest news on Biogen?
On Sep 17, 2026, globenewswire.com reported: Phase 3 Pediatric EMPAVELI Data Published in Clinical Journal of the American Society of Nephrology Show Reduction in Proteinuria and Stabilized Kidney Function in Adolescents. This page tracks 20 news events for Biogen since Oct 10, 2025, each with a date and a source link.
What is going on with Biogen?
In the 90 days to Sep 30, 2026, Autobound tracked 11 news events, 1 10-Q filing, 4 hiring snapshots, 2 deals, 22 signals for Biogen. The newest story is from Sep 17, 2026 (Launch), reported by globenewswire.com.
Has Biogen announced any acquisitions?
The latest deal story is from Aug 7, 2026. pharmabiz.net reported: Biogen Completes Acquisition of Ray Thera. The acquisitions page lists 3 deals with a source for each.
What else does Autobound track for Biogen?
Beyond news and filings, Autobound lists 42+ signals for Biogen from 4 sources: Glassdoor (15+), YouTube (11), LinkedIn (9), Patents (7). See the Biogen signals page for the dated list.
Is Biogen hiring right now?
Yes. As of Sep 29, 2026, Biogen had 43 open roles, and Research and development had the most with 6.

Source. News, SEC filings (8-K, 10-K, 10-Q, Form D), hiring data and other signals (Reddit, podcasts, Glassdoor, reviews, social posts, patents, web traffic) from the Autobound Signal API.

Method. Stories are grouped when they report the same event within 14 days. Rows that do not name the company are removed. Each row links its source.

Data as of .

How this data is built →Get it from the Signal API →